SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee
SRx Health Solutions (NYSE American: SRXH) has announced the appointment of Joshua Epstein to its Board of Directors and Compensation Committee. The announcement represents a straightforward addition to the company's governance structure.
The press release primarily consists of standard forward-looking statements and contact information, with no additional details provided about Epstein's background, qualifications, or specific contributions expected in his new role.
SRx Health Solutions (NYSE American: SRXH) ha annunciato la nomina di Joshua Epstein nel Consiglio di Amministrazione e nel Comitato per la Retribuzione. L'annuncio rappresenta una semplice integrazione nella struttura di governance dell'azienda.
Il comunicato stampa si compone principalmente di dichiarazioni previsionali standard e di informazioni di contatto, senza ulteriori dettagli sul background, sulle qualifiche o sui contributi specifici attesi nel suo nuovo ruolo.
SRx Health Solutions (NYSE American: SRXH) ha anunciado la designación de Joshua Epstein para su Junta Directiva y para el Comité de Remuneraciones. El anuncio representa una simple adición a la estructura de gobernanza de la empresa.
El comunicado de prensa se compone principalmente de declaraciones a futuro estándar y de información de contacto, sin detalles adicionales sobre la trayectoria, las calificaciones o las contribuciones específicas esperadas en su nuevo cargo.
SRx Health Solutions (NYSE American: SRXH) 은 이사회 및 보상위원회에 Joshua Epstein의 임명을 발표했습니다. 이 발표는 회사의 거버넌스 구조에 대한 단순한 추가를 나타냅니다.
보도자료는 주로 표준적인 미래지향적 진술과 연락처 정보로 구성되어 있으며, 새로운 직무에서 Epstein의 배경, 자격 또는 구체적 기여에 대한 추가 세부 정보는 제공되지 않습니다.
SRx Health Solutions (NYSE American: SRXH) a annoncé la nomination de Joshua Epstein au conseil d’administration et au comité de rémunération. L’annonce constitue une simple addition à la structure de gouvernance de l’entreprise.
Le communiqué de presse se compose principalement de déclarations prospectives standard et d’informations de contact, sans détails supplémentaires sur le parcours, les qualifications ou les contributions spécifiques attendues dans son nouveau rôle.
SRx Health Solutions (NYSE American: SRXH) hat die Ernennung von Joshua Epstein in den Vorstand und den Vergütungsausschuss angekündigt. Die Ankündigung stellt eine sachliche Erweiterung der Unternehmensgovernance dar.
Die Pressemitteilung besteht im Wesentlichen aus standardmäßigen zukunftsgerichteten Aussagen und Kontaktinformationen, ohne weitere Details zu Epsteins Hintergrund, Qualifikationen oder zu den spezifischen Beiträgen, die in seiner neuen Rolle erwartet werden.
أعلنت SRx Health Solutions (بورصة NYSE American: SRXH) تعيين Joshua Epstein في مجلس الإدارة ولجنة التعويضات. الإعلان يمثل إضافة مباشرة إلى بنية الحوكمة للشركة. يتكوّن البيان الصحفي أساساً من عبارات تطلعية معيارية ومعلومات الاتصال، دون تفاصيل إضافية حول خلفية Epstein أو مؤهلاته أو المساهمات المحددة المتوقعة في دوره الجديد.
SRx Health Solutions（NYSE American: SRXH）宣布任命 Joshua Epstein 为董事会成员及薪酬委员会成员。这一公告只是对公司治理结构的简单增补。新闻稿主要包含标准的前瞻性陈述和联系信息，未就 Epstein 的背景、资历或在新职位中预期的具体贡献提供额外细节。
- None.
- None.
TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Company Contact:
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com
FAQ
Who is the new board member appointed to SRx Health Solutions (SRXH)?
What positions will Joshua Epstein hold at SRXH?
Who is the current CEO of SRx Health Solutions (SRXH)?
How can investors contact SRx Health Solutions (SRXH)?
